STOCK TITAN

MeiraGTx (MGTX) Perceptive funds gain $8 warrants and new shares

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MeiraGTx Holdings plc reported that investment entities associated with Perceptive Advisors adjusted their equity and warrant positions. Perceptive Life Sciences Master Fund Ltd. now indirectly holds 10,786,658 Ordinary Shares after receiving a grant of 555,555 shares at $9.00 per share on April 17, 2026.

On March 25, 2026, Perceptive Credit Holdings III, LP received two warrant grants covering 300,000 and 400,000 Ordinary Shares at an $8.00 exercise price, expiring on August 2, 2027. On the same date, earlier warrants for 300,000 shares at $20.00 and 400,000 shares at $15.00 were disposed of back to the issuer under a financing agreement adjustment.

Positive

  • None.

Negative

  • None.
Insider PERCEPTIVE ADVISORS LLC, EDELMAN JOSEPH, PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Role null | null | null
Type Security Shares Price Value
Grant/Award Ordinary Shares 555,555 $9.00 $5.00M
Disposition Warrant (Right to Buy) 400,000 $0.00 --
Disposition Warrant (Right to Buy) 300,000 $0.00 --
Grant/Award Warrant (Right to Buy) 400,000 $0.00 --
Grant/Award Warrant (Right to Buy) 300,000 $0.00 --
Grant/Award Warrant (Right to Buy) 400,000 $0.00 --
Grant/Award Warrant (Right to Buy) 300,000 $0.00 --
Holdings After Transaction: Ordinary Shares — 10,786,658 shares (Indirect, See Footnote); Warrant (Right to Buy) — 0 shares (Indirect, See Footnote)
Footnotes (1)
  1. The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Issued to Perceptive Credit Holdings III, LP ("Credit Fund III") in connection with the senior secured financing arrangement (the "Financing Agreement") by and among the Issuer, PCH III, and the other parties thereto. Perceptive Credit Advisors LLC ("Perceptive Credit Advisors") serves as the investment advisor to Credit Fund III and as a relying advisor under the Advisor. Mr. Edelman is the managing member of Perceptive Credit Advisors. Each of Perceptive Credit Advisors, the Advisor and Mr. Edelman disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that any of Perceptive Credit Advisors, the Advisor and Mr. Edelman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. On March 25, 2026, the Issuer, Credit Fund III, and the other parties to the Financing Agreement entered into an agreement whereby the exercise price of the warrants was adjusted to $8.00 per share.
Ordinary share grant 555,555 shares at $9.00 Award of Ordinary Shares on April 17, 2026
Post-grant Ordinary Shares 10,786,658 shares Ordinary Shares indirectly held after April 17, 2026 grant
New warrant 1 300,000 shares at $8.00 Warrant grant on March 25, 2026, expires August 2, 2027
New warrant 2 400,000 shares at $8.00 Second warrant grant on March 25, 2026, expires August 2, 2027
Disposed warrant 1 300,000 shares at $20.00 Warrant disposed to issuer on March 25, 2026
Disposed warrant 2 400,000 shares at $15.00 Warrant disposed to issuer on March 25, 2026
Perceptive Life Sciences Master Fund Ltd. financial
"The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund")."
Perceptive Credit Holdings III, LP financial
"Issued to Perceptive Credit Holdings III, LP ("Credit Fund III") in connection with the senior secured financing arrangement"
senior secured financing arrangement financial
"in connection with the senior secured financing arrangement (the "Financing Agreement") by and among the Issuer, PCH III, and the other parties thereto."
Financing Agreement financial
"the senior secured financing arrangement (the "Financing Agreement") by and among the Issuer, PCH III, and the other parties thereto."
disposition to issuer financial
"transaction_action": "issuer disposition","transaction_code_description": "Disposition to issuer""
indirect pecuniary interest financial
"disclaims ... beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PERCEPTIVE ADVISORS LLC

(Last)(First)(Middle)
51 ASTOR PLACE, 10TH FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MeiraGTx Holdings plc [ MGTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/02/2022
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares04/17/2026A555,555A$910,786,658ISee Footnote(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant (Right to Buy)$1508/02/2022A400,00008/02/202208/02/2027Ordinary Shares400,000(2)400,000ISee Footnote(2)
Warrant (Right to Buy)$2008/02/2022A300,00008/02/202208/02/2027Ordinary Shares300,000(2)300,000ISee Footnote(2)
Warrant (Right to Buy)$1503/25/2026D400,00008/02/202208/02/2027Ordinary Shares400,000(3)0ISee Footnote(2)
Warrant (Right to Buy)$2003/25/2026D300,00008/02/202208/02/2027Ordinary Shares300,000(3)0ISee Footnote(2)
Warrant (Right to Buy)$803/25/2026A400,00003/25/202608/02/2027Ordinary Shares400,000(3)400,000ISee Footnote(2)
Warrant (Right to Buy)$803/25/2026A300,00003/25/202608/02/2027Ordinary Shares300,000(3)300,000ISee Footnote(2)
1. Name and Address of Reporting Person*
PERCEPTIVE ADVISORS LLC

(Last)(First)(Middle)
51 ASTOR PLACE, 10TH FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
EDELMAN JOSEPH

(Last)(First)(Middle)
51 ASTOR PLACE, 10TH FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

(Last)(First)(Middle)
51 ASTOR PLACE, 10TH FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
2. Issued to Perceptive Credit Holdings III, LP ("Credit Fund III") in connection with the senior secured financing arrangement (the "Financing Agreement") by and among the Issuer, PCH III, and the other parties thereto. Perceptive Credit Advisors LLC ("Perceptive Credit Advisors") serves as the investment advisor to Credit Fund III and as a relying advisor under the Advisor. Mr. Edelman is the managing member of Perceptive Credit Advisors. Each of Perceptive Credit Advisors, the Advisor and Mr. Edelman disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that any of Perceptive Credit Advisors, the Advisor and Mr. Edelman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
3. On March 25, 2026, the Issuer, Credit Fund III, and the other parties to the Financing Agreement entered into an agreement whereby the exercise price of the warrants was adjusted to $8.00 per share.
Remarks:
Ellen Hukkelhoven, the Head of Investment Research of the Advisor, is a member of the Issuer's board of directors.
/s/ Perceptive Advisors LLC, By: Joseph Edelman, its managing member04/23/2026
/s/ Joseph Edelman - for Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager, By: Joseph Edelman, its managing member04/23/2026
/s/ Joseph Edelman04/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity grant did Perceptive receive in MeiraGTx (MGTX)?

Perceptive Life Sciences Master Fund Ltd. received a grant of 555,555 MeiraGTx Ordinary Shares at $9.00 per share, bringing its indirect holdings to 10,786,658 shares. The grant was reported as an acquisition under a compensation or award-type transaction.

How did MeiraGTx (MGTX) warrants held by Perceptive Credit Holdings III change?

Perceptive Credit Holdings III, LP was issued two warrants for 300,000 and 400,000 MeiraGTx Ordinary Shares, both with an $8.00 per share exercise price and expiring August 2, 2027. These were part of adjustments to an existing senior secured financing arrangement.

Which MeiraGTx (MGTX) warrants were disposed of back to the issuer?

Warrants covering 300,000 Ordinary Shares at a $20.00 exercise price and 400,000 Ordinary Shares at a $15.00 exercise price were disposed of to MeiraGTx. Both dispositions occurred on March 25, 2026 as transactions to the issuer, eliminating those higher-strike warrants.

What agreement affected MeiraGTx (MGTX) warrant exercise prices?

On March 25, 2026, MeiraGTx, Perceptive Credit Holdings III, LP, and other parties amended their senior secured financing agreement. This agreement adjusted the exercise price of certain warrants to $8.00 per share, aligning with the new warrant grants expiring August 2, 2027.

Who is reported as holding MeiraGTx (MGTX) securities in this Form 4?

The Form 4 attributes Ordinary Shares to Perceptive Life Sciences Master Fund Ltd. and certain warrants to Perceptive Credit Holdings III, LP. Perceptive Advisors LLC and Joseph Edelman are linked as managers but disclaim beneficial ownership except for any indirect pecuniary interest.

What is the nature of ownership for MeiraGTx (MGTX) positions in this filing?

All reported positions are indirect, held through funds such as Perceptive Life Sciences Master Fund Ltd. and Perceptive Credit Holdings III, LP. The advisors and Joseph Edelman disclaim beneficial ownership for Section 16 purposes, except for any indirect pecuniary interest described in the footnotes.